Chemical formula: C₂₇H₃₀Cl₂O₆ Molecular mass: 427.361 g/mol PubChem compound: 441335
Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D07AC13 | Mometasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III) |
| D07XC03 | Mometasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XC Corticosteroids, potent, other combinations |
| R01AD09 | Mometasone | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids |
| R03BA07 | Mometasone | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| MOMETASONE FUROATE Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ASMANEX TWISTHALER Inhalation powder | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ELOCON Cream, 0.1% | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| NASONEX Nasal Spray, Suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ELOCON Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ELOCON Lotion, 0.1% | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| NASONEX Nasal spray | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Mometasone is an active ingredient of these brands:
United States (US)Australia (AU)Austria (AT)
Brazil (BR)Canada (CA)Croatia (HR)
Ecuador (EC)
Estonia (EE)
Finland (FI)
France (FR)Germany (DE)
Hong Kong (HK)
Ireland (IE)
Israel (IL)Japan (JP)
Lithuania (LT)
Malta (MT)
Netherlands (NL)
New Zealand (NZ)Poland (PL)
Romania (RO)Singapore (SG)
South Africa (ZA)
Spain (ES)Turkey (TR)
United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
